Jun 12, 2024 | Diabetes Institute, Meetings, Research, Seminar, Symposium
Tuesday, 10 September – Friday, 13 September 2024 in Madrid
Dec 21, 2023 | Diabetes Institute, From inflammation to cancer in digestive diseases, Publications
This article discusses the origin of pancreatic lesions associated with pancreatic cancer. Pancreatic ductal adenocarcinoma (PDAC) is currently the fourth leading cause of cancer death worldwide. It is projected to become the second leading cause of cancer death by...
Nov 15, 2023 | Diabetes Institute, Seminar, Symposium
Vendredi 1er décembre 2023 (Amphi Vulpian) 9h15-9h30 Welcome 9h30-9h40: presentation of the day… 9h40-11h00: Session 1: Newcomers 9h40-10h00: Benoit Viollet: Targeting AMPK and AMPK-related protein kinases to control blood glucose levels 10h00-10h20: Ralf Jockers: Why...
Nov 12, 2023 | Diabetes Institute, Functional Pharmacology and Pathophysiology of Membrane Receptors, Publications, Research
This study, from Ralf Jockers and Julie Dam’s team as part of a European network for the prevention of childhood obesity, OBELISK,defines impaired GLP1R cell surface expression as a risk factor for traits associated with type 2 diabetes and obesity and provides...
Nov 12, 2023 | Diabetes Institute, Functional pancreatic beta cell mass in rodent and human, Publications, Research, T-cell tolerance, biomarkers and therapies in type 1 diabetes
A collaborative work between the teams of R Mallone and R Scharfmann leaded by L Rachdi indicate that TRP could induce immune tolerance to β cells by promoting their immune evasion through HLA-I downregulation and PD-L1 upregulation.
